XML 37 R25.htm IDEA: XBRL DOCUMENT v3.25.1

INVESTMENTS IN EQUITY SECURITIES (Tables)

3 Months Ended

Mar. 31, 2025

Schedule of Investments [Abstract]

SCHEDULE OF INVESTMENTS

The following table summarizes the Company’s investments for the periods presented:

 SCHEDULE OF INVESTMENTS 

		March 31, 2025								December 31, 2024
		Carrying Amount				Economic Interest				Carrying Amount				Economic Interest
Equity Method Investments
ChemoMouthpiece, LLC		$	5,098,210				6.59	%		$	5,172,242				6.59	%
SI Healthcare Technologies, LLC			40,703				50.00	%			40,703				50.00	%
Biomimetic Innovations Limited			4,551,370				6.67	%			-				-	%
Total Equity Method Investments		$	9,690,283							$	5,212,945
Cost Method Investments
Direct Dermatology, Inc.		$	1,000,000							$	1,000,000
Pixalere Healthcare Inc.			-								2,084,278
Total Cost Method Investments		$	1,000,000							$	3,084,278
Total Investments		$	10,690,283							$	8,297,223

SCHEDULE OF LOSS FROM EQUITY METHOD INVESTMENT

The following table summarizes the Company’s share of losses from equity method investments reflected in the Company’s Consolidated Statements of Operations for the periods presented:

 SCHEDULE OF LOSS FROM EQUITY METHOD INVESTMENT 

		2025				2024
		Three Months Ended March 31,
		2025				2024
Investments
ChemoMouthpiece, LLC		$	(74,032	)		$	-
SI Healthcare Technologies, LLC			-				-
Biomimetic Innovations Limited			(69,576	)			-
Total		$	(143,608	)		$	-
Loss from equity method investment		$	(143,608	)		$	-

X

- Definition

Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 323
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481687/323-10-50-3

+ Details

Name:	us-gaap_EquityMethodInvestmentsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of realized and unrealized gain (loss) on investment in security.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(9)(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(7)(c))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

+ Details

Name:	us-gaap_GainLossOnInvestmentsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfInvestmentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration